Details for New Drug Application (NDA): 062464
✉ Email this page to a colleague
NDA 062464 describes CEPHALOTHIN SODIUM, which is a drug marketed by Abbott, Abraxis Pharm, Bristol, and Baxter Hlthcare, and is included in six NDAs. Additional details are available on the CEPHALOTHIN SODIUM profile page.
The generic ingredient in CEPHALOTHIN SODIUM is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
The generic ingredient in CEPHALOTHIN SODIUM is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Summary for 062464
| Tradename: | CEPHALOTHIN SODIUM |
| Applicant: | Bristol |
| Ingredient: | cephalothin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062464
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | May 7, 1984 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | May 7, 1984 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4GM BASE/VIAL | ||||
| Approval Date: | May 7, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
